ABOVE
What it found
We found no results in the registry or in papers.
This trial finished 21 years ago. We found no results in the registry or in any paper that cites it.
What was tested
Treatment tested
- Interferon beta-1b
Interferon alpha/beta receptor agonist
Compared with
- Interferon beta-1b
Interferon alpha/beta receptor agonist
What it measured
Main measures
Time to onset of first relapse
Time to onset of first relapse
Relapses
Other measures (1)
Number of patients relapse free at week 104
At week 104
Relapses
Who could take part
Relapsing MS · 18 to 60
Inclusion Criteria: * RRMS patients that are receiving treatment with Avonex 30 µg once weekly Exclusion Criteria: * Primary Progressive or Secondary Progressive MS
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
The purpose of this study is to determine the difference in preventing a relapse between Betaseron and Avonex. Patients with RRMS currently treated with Avonex will be randomized into 2 equal-size arms; one arm will continue on the standard dose of Avonex; one arm will be converted to Betaseron standard dose.
Papers
Loading reviews and guidelines…
Related trials
- TWINS
Phase 3 · Not yet recruiting
Still running
- Pregnancy Exposure Registry for Vumerity (Diroximel Fumar…
Recruiting
Still running
- Full Responders
Phase 4 · Stopped early
Stopped early
- A Study to Learn More About The Safety of Diroximel Fumar…
Running, not recruiting
Still running
- Study to Investigate Pregnancy Outcomes in Female Partici…
Completed
Result in a paper, not read yet
- 105MS306
Phase 3 · Running, not recruiting
Still running
History
Started
Mar 2003
Finished
Oct 2005
Assembled by software from public sources and not checked by people. Each record links to its source. Report an error